| Veröffentlichte Version Download ( PDF | 143kB) |
Test Performance Characteristics of Anti-HEV IgG Assays Strongly Influence Hepatitis E Seroprevalence Estimates
Wenzel, Jürgen J.
, Preiss, Julia, Schemmerer, Mathias
, Huber, Barbara und Jilg, Wolfgang
(2012)
Test Performance Characteristics of Anti-HEV IgG Assays Strongly Influence Hepatitis E Seroprevalence Estimates.
The Journal of Infectious Diseases 207 (3), S. 497-500.
Veröffentlichungsdatum dieses Volltextes: 13 Aug 2018 12:57
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.37519
Zusammenfassung
Hepatitis E virus (HEV) seroprevalences of 0.3%-53% were reported from industrialized countries. Because these estimates may be influenced by detection assays, this study compares 3 frequently used tests for HEV detection: the MP Diagnostics HEV immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA), the Axiom Diagnostics HEV IgG enzyme immunoassay (EIA), and the Mikrogen recomLine HEV ...
Hepatitis E virus (HEV) seroprevalences of 0.3%-53% were reported from industrialized countries. Because these estimates may be influenced by detection assays, this study compares 3 frequently used tests for HEV detection: the MP Diagnostics HEV immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA), the Axiom Diagnostics HEV IgG enzyme immunoassay (EIA), and the Mikrogen recomLine HEV IgG assay. Sera from 200 healthy healthcare workers and 30 individuals with acute HEV infection were analyzed. Among the healthy individuals, HEV IgG was found in 4.5% by the MP Diagnostics assay, in 29.5% by the Axiom Diagnostics assay, and in 18% by the Mikrogen assay. Among individuals with acute HEV infection, positive results were obtained for 83.3%, 100%, and 96.7%, respectively. Thus, the 3 assays show clear differences in diagnostic sensitivity.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | The Journal of Infectious Diseases | ||||
| Verlag: | OXFORD UNIV PRESS INC | ||||
|---|---|---|---|---|---|
| Ort der Veröffentlichung: | CARY | ||||
| Band: | 207 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 3 | ||||
| Seitenbereich: | S. 497-500 | ||||
| Datum | 2012 | ||||
| Institutionen | Medizin > Lehrstuhl für Medizinische Mikrobiologie und Hygiene | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | E-VIRUS-ANTIBODIES; BLOOD-DONORS; GERMANY; TRANSMISSION; INFECTION; SEQUENCE; FRANCE; Hepatitis E; HEV; anti-HEV IgG; seroprevalence; serology; diagnostic sensitivity; commercial assays; acute infection; southeastern Germany | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-375192 | ||||
| Dokumenten-ID | 37519 |
Downloadstatistik
Downloadstatistik